Alternative Data for Inmode
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 2 | Sign up | Sign up | Sign up |
| Sentiment | 91 | Sign up | Sign up | Sign up |
| Webpage traffic | 43,000 | Sign up | Sign up | Sign up |
| Employee Rating | 62 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| Patents | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 574 | Sign up | Sign up | Sign up |
| Facebook Followers | 17,865 | Sign up | Sign up | Sign up |
| Instagram Followers | 108,846 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 7 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 6,512 | Sign up | Sign up | Sign up |
| X Followers | 1,395 | Sign up | Sign up | Sign up |
| X Mentions | 4 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 7,190 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 47 | Sign up | Sign up | Sign up |
| Linkedin Employees | 525 | Sign up | Sign up | Sign up |
About Inmode
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally.
| Price | $13.54 |
| Target Price | Sign up |
| Volume | 1,462,241 |
| Market Cap | $858M |
| Year Range | $12.76 - $16.62 |
| Dividend Yield | 0% |
| PE Ratio | 9.47 |
| Analyst Rating | 40% buy |
| Industry | Medical Devices |
In the news
 |
InMode (INMD) Stock Slips As Board Ends ReviewFebruary 22 - Benzinga |
 |
InMode Ltd. (NASDAQ:INMD) Reports Q4 2025 Earnings Beat Amid Revenue ShortfallFebruary 9 - ChartMill |
 |
InMode Ltd. (INMD) Q4 2025 Earnings Call TranscriptFebruary 9 - SeekingAlpha |
 |
InMode Board Approves Buyback Covering Nearly 10% Of StockMarch 12 - Benzinga |
InMode Board Approved A New Buyback Plan Of Up To ~10% Of Total Shares OutstandingMarch 12 - Benzinga |
|
InMode shares are trading lower after the company announced its independent transaction committee completed its reviews of proposals received in connection with a potential transaction and concluded that none are adequate.February 22 - Benzinga |
|
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '25 | 93M | 21M | 72M | 22M | 26M | 0.380 |
| Q2 '25 | 96M | 19M | 76M | 27M | 31M | 0.470 |
| Q1 '25 | 78M | 17M | 61M | 18M | 16M | 0.310 |
| Q4 '24 | 98M | 20M | 78M | 83M | 28M | 1.140 |
| Q3 '24 | 130M | 24M | 106M | 51M | 48M | 0.700 |
Insider Transactions View All
No recorded Insider transactions.
Similar companies
Read more about Inmode (INMD) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, x followers, x mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
FAQ - Inmode
The Market Cap of Inmode is $858M.
As of today, Inmode's PE (Price to Earnings) ratio is 9.47.
Currently, the price of one share of Inmode stock is $13.54.
The INMD stock price chart above provides a comprehensive visual representation of Inmode's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Inmode shares. Our platform offers an up-to-date INMD stock price chart, along with technical data analysis and alternative data insights.
As of our latest update, Inmode (INMD) does not offer dividends to its shareholders. Investors interested in Inmode should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
Some of the similar stocks of Inmode are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.
